{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:42:07Z","timestamp":1770414127870,"version":"3.49.0"},"reference-count":39,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":3392,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n                  <jats:p>Retinal neovascularization is observed in progression of diabetic retinopathy. New vessels grow into the vitreous cavity in proliferative diabetic retinopathy, resulting in traction retinal detachment and vitreous hemorrhage. To overcome the catastrophic visual loss due to these complications, efforts have been focused on the treatment of retinal neovascularization. In this study, we demonstrated the inhibitory effect of recombinant human apolipoprotein(a) kringle V (rhLK8) in an animal model of ischemia-induced retinal neovascularization. rhLK8 induced no definite toxicity on endothelial cells and retinal tissues at the therapeutic dosage. Interestingly, rhLK8 showed antiangiogenic effect, particularly on fibronectin-mediated migration of endothelial cells. Further experiments demonstrated high binding affinity of rhLK8 to \u03b13\u03b21 integrin, and suppression of it might be the mechanism of antiangiogenic effect of rhLK8. Furthermore, rhLK8 inhibited phosphorylation of focal adhesion kinase, resulting in suppression of activation of consequent p130CAS-Jun NH2-terminal kinase. Taken together, our data suggested the possible application of rhLK8 in the treatment of retinal neovascularization by suppression of fibronectin-mediated angiogenesis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db11-1541","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T01:46:45Z","timestamp":1331948805000},"page":"1599-1608","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":18,"title":["Human Apolipoprotein(a) Kringle V Inhibits Ischemia-Induced Retinal Neovascularization via Suppression of Fibronectin-Mediated Angiogenesis"],"prefix":"10.2337","volume":"61","author":[{"given":"Yangmi","family":"Lim","sequence":"first","affiliation":[{"name":"Mogam Biotechnology Research Institute, Yongin, Kyonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hyun","family":"Jo","sequence":"additional","affiliation":[{"name":"Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea"},{"name":"Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea"},{"name":"Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hyung","family":"Ahn","sequence":"additional","affiliation":[{"name":"Mogam Biotechnology Research Institute, Yongin, Kyonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Kyeong","family":"Hwang","sequence":"additional","affiliation":[{"name":"Mogam Biotechnology Research Institute, Yongin, Kyonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ku","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Chungbuk National University, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Ik","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Chungbuk National University, Cheongju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Suk","family":"Yu","sequence":"additional","affiliation":[{"name":"Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea"},{"name":"Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeup","family":"Yoon","sequence":"additional","affiliation":[{"name":"Mogam Biotechnology Research Institute, Yongin, Kyonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Hun","family":"Kim","sequence":"additional","affiliation":[{"name":"Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea"},{"name":"Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea"},{"name":"Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"2022031210123399700_B1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s12272-010-1007-6","article-title":"How to overcome retinal neuropathy: the fight against angiogenesis-related blindness","volume":"33","author":"Jo","year":"2010","journal-title":"Arch Pharm Res"},{"key":"2022031210123399700_B2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"2022031210123399700_B3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy","volume":"350","author":"Frank","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031210123399700_B4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1084952102000940","article-title":"The extracellular matrix as a scaffold for tissue reconstruction","volume":"13","author":"Badylak","year":"2002","journal-title":"Semin Cell Dev Biol"},{"key":"2022031210123399700_B5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0014-4835(05)80079-X","article-title":"Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy","volume":"60","author":"Casaroli Marano","year":"1995","journal-title":"Exp Eye Res"},{"key":"2022031210123399700_B6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/02713680802585946","article-title":"Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy","volume":"34","author":"George","year":"2009","journal-title":"Curr Eye Res"},{"key":"2022031210123399700_B7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.2003.026542","article-title":"Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus","volume":"88","author":"Probst","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"2022031210123399700_B8","first-page":"258","article-title":"Fibronectin overexpression in retinal microvessels of patients with diabetes","volume":"37","author":"Roy","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022031210123399700_B9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1167\/iovs.08-2377","article-title":"Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats","volume":"50","author":"Cherian","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022031210123399700_B10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2003.11.148","article-title":"Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases","volume":"313","author":"Kim","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031210123399700_B11","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M301042200","article-title":"Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a)","volume":"278","author":"Kim","year":"2003","journal-title":"J Biol Chem"},{"key":"2022031210123399700_B12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1568011023353705","article-title":"Kringle structures and antiangiogenesis","volume":"2","author":"Cao","year":"2002","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"2022031210123399700_B13","first-page":"585","article-title":"Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth","volume":"31","author":"Kim","year":"2007","journal-title":"Int J Oncol"},{"key":"2022031210123399700_B14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jbiotec.2006.05.011","article-title":"Disruption of hexokinase II (HXK2) partly relieves glucose repression to enhance production of human kringle fragment in gratuitous recombinant Saccharomyces cerevisiae","volume":"126","author":"Lee","year":"2006","journal-title":"J Biotechnol"},{"key":"2022031210123399700_B15","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1271\/bbb.70.916","article-title":"Crystallization of antiangiogenic Kringle V derived from human apolipoprotein A: crystallization applied to purification and formulation","volume":"70","author":"Kang","year":"2006","journal-title":"Biosci Biotechnol Biochem"},{"key":"2022031210123399700_B16","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/j.1582-4934.2008.00243.x","article-title":"Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy","volume":"12","author":"Kim","year":"2008","journal-title":"J Cell Mol Med"},{"key":"2022031210123399700_B17","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022031210123399700_B18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2006-06-029298","article-title":"Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice","volume":"109","author":"Min","year":"2007","journal-title":"Blood"},{"key":"2022031210123399700_B19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1124\/jpet.107.132720","article-title":"Antiangiogenic effect of deguelin on choroidal neovascularization","volume":"324","author":"Kim","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"2022031210123399700_B20","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/pmic.200300541","article-title":"ProteoChip: a highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein-protein interaction studies","volume":"3","author":"Lee","year":"2003","journal-title":"Proteomics"},{"key":"2022031210123399700_B21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0026-2862(77)90141-8","article-title":"Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis","volume":"14","author":"Ausprunk","year":"1977","journal-title":"Microvasc Res"},{"key":"2022031210123399700_B22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc2353","article-title":"Integrins in angiogenesis and lymphangiogenesis","volume":"8","author":"Avraamides","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2022031210123399700_B23","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1096\/fj.02-0691fje","article-title":"Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation","volume":"17","author":"Hutchings","year":"2003","journal-title":"FASEB J"},{"key":"2022031210123399700_B24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1538-7836.2007.02569.x","article-title":"Cell-matrix adhesion in vascular development","volume":"5","author":"Hynes","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2022031210123399700_B25","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/ATVBAHA.108.172015","article-title":"Integrins: the keys to unlocking angiogenesis","volume":"28","author":"Silva","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210123399700_B26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21149","article-title":"Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice","volume":"43","author":"Lee","year":"2006","journal-title":"Hepatology"},{"key":"2022031210123399700_B27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000223939","article-title":"Vitreous as a substrate for vitreolysis","volume":"44","author":"Bishop","year":"2009","journal-title":"Dev Ophthalmol"},{"key":"2022031210123399700_B28","first-page":"186","article-title":"Plasma fibronectin in diabetic retinopathy and macroangiopathy","volume":"12","author":"Seghieri","year":"1986","journal-title":"Diabete Metab"},{"key":"2022031210123399700_B29","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1242\/jcs.00670","article-title":"The ins and outs of fibronectin matrix assembly","volume":"116","author":"Wierzbicka-Patynowski","year":"2003","journal-title":"J Cell Sci"},{"key":"2022031210123399700_B30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-005-9017-6","article-title":"EDB fibronectin and angiogenesis\u2014 a novel mechanistic pathway","volume":"8","author":"Khan","year":"2005","journal-title":"Angiogenesis"},{"key":"2022031210123399700_B31","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1242\/jcs.018044","article-title":"Paxillin comes of age","volume":"121","author":"Deakin","year":"2008","journal-title":"J Cell Sci"},{"key":"2022031210123399700_B32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0969-2126(02)00717-7","article-title":"The structural basis of localization and signaling by the focal adhesion targeting domain","volume":"10","author":"Arold","year":"2002","journal-title":"Structure"},{"key":"2022031210123399700_B33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1242\/jcs.018093","article-title":"Integrin signalling at a glance","volume":"122","author":"Harburger","year":"2009","journal-title":"J Cell Sci"},{"key":"2022031210123399700_B34","doi-asserted-by":"crossref","first-page":"21785","DOI":"10.1074\/jbc.R000003200","article-title":"Ligand binding to integrins","volume":"275","author":"Plow","year":"2000","journal-title":"J Biol Chem"},{"key":"2022031210123399700_B35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00232-004-0696-5","article-title":"Physiological and pathological roles of alpha3beta1 integrin","volume":"200","author":"Tsuji","year":"2004","journal-title":"J Membr Biol"},{"key":"2022031210123399700_B36","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"2022031210123399700_B37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0962-8924(01)02152-3","article-title":"Integrin signaling revisited","volume":"11","author":"Schwartz","year":"2001","journal-title":"Trends Cell Biol"},{"key":"2022031210123399700_B38","first-page":"1501","article-title":"Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion","volume":"31","author":"Van Slambrouck","year":"2007","journal-title":"Int J Oncol"},{"key":"2022031210123399700_B39","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/MCB.18.5.2571","article-title":"Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2\/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events","volume":"18","author":"Schlaepfer","year":"1998","journal-title":"Mol Cell Biol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/61\/6\/1599\/569453\/1599.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/61\/6\/1599\/569453\/1599.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:29:15Z","timestamp":1667406555000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/61\/6\/1599\/15490\/Human-Apolipoprotein-a-Kringle-V-Inhibits-Ischemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,5,14]]},"published-print":{"date-parts":[[2012,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db11-1541","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}